All the following posted with links to original sources, but without permission
comments on Twitter:
"That woman could eat corn on the cob through a fence."
"Something is going on with her boyfriend klaus schwab NOT being at the WEF forum The CEO of Pfizer resigning** and now the Ho Ho Ho Jacinta Ardern quitting Something has happened that they were not planning on. Hard to say what but we need to get to the bottom of it ASAP....
"Just three days after you reported how her cabinet ignored recommendations from health experts on the vaccine roll out in NZ... interesting timing here"
CAUGHT HIM! Rebel News pummels Pfizer CEO with questions at World Economic Forum
Avi Yemini and I were standing on the street at the World Economic Forum in Davos, Switzerland, when we spotted Albert Bourla, the CEO of Pfizer, walking by.
By Ezra Levant
January 19, 2023
It was the moment we were waiting for: one of the most hated men in the world going for a leisurely stroll because he assumed he was amongst friends. After all, in the three years since the pandemic began, have you ever seen a journalist ask him a tough question?
Well, he didn’t count on Rebel News and our accountability style of citizen journalism.
I walked right up to him and started asking him the questions that millions of people have surely been wondering for years. And a moment later, Avi joined in, making it a sort of walking press conference. And Bourla couldn’t answer a single question.
You know, there are hundreds of “accredited” journalists here at the World Economic Forum — the biggest names in news, from CNN to the New York Times. But you have to understand: they’re all here as WEF members, not to hold the WEF to account. They’re on Pfizer’s team. They would never ask Pfizer a tough question.
https://www.rebelnews.com/every_question_we_asked_pfizer_ceo_albert_bourla
Here’s a sample of the one-sided conversation:
LEVANT: Mr. Bourla, can I ask you, when did you know that the vaccines didn’t stop transmission? How long did you know that without saying it publicly?
BOURLA: Thank you very much.
LEVANT: Why won’t you answer that question? I mean we now know that the vaccines didn’t stop transmission, but why did you keep it secret? [Pause; Bourla is non-responsive.] You said it was 100 percent effective, then 90 percent, then 80 percent, then 70 percent, but we now know that the vaccines do not stop transmission. Why did you keep that secret?
BOURLA: Have a nice day.
LEVANT: I won’t have a nice day until I know the answer.
I usually am not a fan of journalists shouting questions at unwilling politicians outside of Congress and such, because the person is unlikely to answer and it’s simply unbecoming to be yelling at people just walking to their office. But Levan and Ali are not screaming, they’re not threatening; they’re calmly posing Bourla the questions we all want to ask—and he refuses to answer a single one of them.
Although Bourla was double-vaxxed and double-boosted in the fall of 2022, he nevertheless tested positive for the China-born virus in August—and then got it again in September. That certainly doesn’t look good for his main product, the mRNA vax, but it’s also bad news for Pfizer’s other offering, the anti-viral drug Paxlovid. Used to treat symptoms of the virus, Paxlovid has been linked to “rebound COVID,” which President Joe Biden, First Lady Jill Biden, former White House chief medical adviser, Dr. Anthony Fauci, and others all experienced.
I would like to let you know that I have tested positive for #COVID19. I am thankful to have received four doses of the Pfizer-BioNTech vaccine, and I am feeling well while experiencing very mild symptoms. I am isolating and have started a course of Paxlovid.
— Albert Bourla (@AlbertBourla) August 15, 2022
Wall Street estimates that Pfizer will pull in $99.5 to $102 billion in revenue in 2022. And yet, he couldn’t answer a single question about the efficacy and safety of his products? Levant continues:
Between Avi and I, we asked 29 questions. Everything we have been wanting to ask the Pfizer CEO for three years — from how much he has personally profited from the pandemic, to how much he has paid others to promote his vaccines, to important questions about when he knew his vaccines didn’t actually stop transmission, and why he kept it a secret.
Millions of people around the world were forced to take Pfizer’s ineffective vaccines due to government and business mandates, and an untold number experienced vaccine injuries. It’s shameful that Bourla refuses to answer for anything, and it’s equally shameful that despite there being an army of “accredited” journalists at Davos, not a single one will ask Bourla these questions.
[Bob Hoge is a RedState contributor, proud father and small-business owner. He is shown sporting his Covid beard, which his wife has since forced him to shave. Say hi on Twitter @Bob_Hoge_CA]
~~~~~~~~~~~~~~~~~~
**As for Bourla resigning, check out all the fact-checkers, denying it:
https://search.brave.com/search?q=bourla+resigns
Albert Bourla, Pfizer’s CEO, found guilty of making “disgracefully misleading” statements about child vaccination
December 2, 2022 0 611
by Ethan Huff, Natural News:
The Association of the Prescription Medicines Code of Practice Authority (PMCPA), a regulatory body that governs pharmaceuticals and vaccines in the United Kingdom, has come forward with guns blazing to chastise Pfizer CEO Albert Bourla for making “disgracefully misleading” statements about childhood vaccination.
Last year, Bourla told the BBC children as young as five needed to get injected with his company’s Wuhan coronavirus (Covid-19) “vaccine,” claiming it to be perfectly safe and effective for little ones.
~~~~~~~~~~~~~~~~~~
But not so long ago, FORBES MAGAZINE - MARCH 2021
Pfizer CEO Albert Bourla Helped Save The World. Can He Save His Company’s Stock?
he one-year anniversary of the pandemic was a whirlwind for the chief executive officer who has become defined by it. Pfizer’s Albert Bourla conducted several media interviews on Thursday—everything from CNBC and “Morning Joe” to his first television appearance in Israel, the small country where Pfizer is conducting a massive experiment of its Covid-19 vaccine. After the interviews, Bourla held a long meeting with Pfizer’s group of scientist, manufacturing and distribution officials in charge of making 2 billion doses of the vaccine available this year. He also spent some time reviewing Pfizer’s general corporate strategy.
The success of Pfizer’s medical breakthrough continues to mount. Earlier this week, Bourla was informed that data from Israel showed the vaccine, invented and co-developed by Germany’s BioNTech, was 94% effective against asymptomatic SARS-CoV-2 infections two weeks after a second dose. It was another sign that Pfizer’s vaccine is an exceptional tool for combatting the pandemic. This week Bourla, 59, wearing a blue “science will win” mask and matching shirt, himself received his second dose of the vaccine at Pfizer’s Manhattan headquarters, having been careful not to cut the vaccination line.
“It’s an extraordinary experience for me,” Bourla says about his last year leading Pfizer. “Humanity was—suddenly without expecting that we will be in that position—investing all their hopes in us. That created tremendous pressure.”
Bourla and Pfizer have received accolades from around the world for what they accomplished—supplying a game-changing vaccine to the nightmare virus in less than one year. President Joe Biden recently visited Pfizer’s manufacturing facility in Kalamazoo, Mich., just to give thanks to the company that developed the first Covid-19 vaccine authorized by the Food and Drug Administration.
“I came here because I want the American people to understand the extraordinary work that is being done to undertake the most difficult operational challenge this nation has ever faced,” Biden said while standing on a stage next to Bourla.
But there is one constituency that emphatically does not appreciate Pfizer’s efforts to find a scientific solution to the virus plague. Stock market investors have simply not been impressed. Despite Pfizer’s projection that the vaccine will generate $15 billion of revenues this year, Pfizer’s stock is trading around the same level as it did on the eve of the pandemic, even as the broader stock market has surged higher. In fact, Pfizer’s stock is down 15% since Bourla started his run at the top of Pfizer in January 2019.
It’s glaring that Moderna has become a stock market darling. The small biotechnology company that developed the second Covid-19 vaccine approved in the U.S., using the same cutting-edge technology as Pfizer’s vaccine, has seen its stock soar by 529% in the pandemic. With the Covid-19 vaccine its only commercial product, Moderna’s $56 billion market capitalization is now nearly a third the size of giant Pfizer’s valuation. BioNTech, the small German biotech company that is Pfizer’s Covid-19 vaccine partner, has also seen its stock soar.
When you are helping to save the world from a global public health crisis, you can’t please everyone. “I am frustrated,” says Bourla. “We deserve to be credited. But the current stock price is a huge disappointment.”
When Bourla is feeling down about the issue, he recalls the words of Ian Read, the Pfizer CEO who preceded him, who would tell Bourla that delivering for stock holders was a marathon and not a sprint. Developing the vaccine has been a sprint and Bourla is convinced investors will soon figure out that Pfizer’s stock is undervalued.
Stock market investors, of course, are not the only group to whom Bourla needs to pay close attention to these days. With the vaccine, he has taken on a huge responsibility and it’s not easy to manage. The politics of manufacturing and distributing the Pfizer vaccine has been fraught with tradeoffs and Bourla hears from leaders of countries who feel they are not getting their doses fast enough. But distributing the vaccine to people who need it might come faster than solving Pfizer’s stock market issues.
“The biggest misconception of the pharma business model is that whatever is good for shareholders is bad for patients. In fact, the reverse is true,” says Bourla.
--
The greatest homage we can pay to truth is to use it.
Ralph Waldo Emerson
Debbie downer says, who will replace Ardern? Why now? Seems a false hope flag, a little bit of slack before the noose is tightened.